-
Posted by
Two Blokes Jun 4 -
Filed in
Stock
-
8 views
Alvotech (NASDAQ: ALVO, ALVO-SDB), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has completed its transaction with Xbrane Biopharma AB (“Xbrane”), with the acqusition of the R&D organization of Xbrane in Sweden and biosimilar candidate to Cimzia\u00ae (certolizumab pegol). All regulatory conditions have been fulfilled.
